UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of 3‑(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl‑3H‑imidazo[4,5‑b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6455-6469

2016

Volltextzugriff (PDF)

Discovery of imidazo[1,2- b]pyridazines as IKKβ inhibitors. Part 3: Exploration of effective compounds in arthritis models

Bioorganic & medicinal chemistry letters, 2011-08, Vol.21 (15), p.4550-4555

2011

Volltextzugriff (PDF)

Discovery of imidazo[1,2- b]pyridazines as IKKβ inhibitors. Part 2: Improvement of potency in vitro and in vivo

Bioorganic & medicinal chemistry letters, 2011-02, Vol.21 (3), p.904-908

2011

Volltextzugriff (PDF)

Enantioselective Total Synthesis of Guanacastepene N Using an Uncommon 7-Endo Heck Cyclization as a Pivotal Step

Journal of the American Chemical Society, 2006-10, Vol.128 (40), p.13095-13101

2006

Volltextzugriff (PDF)

A Novel Inhibitor of I-KappaB Kinase Beta Ameliorates Experimental Arthritis through Downregulation of Proinflammatory Cytokines in Arthritic Joints

Biological and Pharmaceutical Bulletin, 2014/01/01, Vol.37(1), pp.87-95

2014

Volltextzugriff (PDF)

Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist

Journal of medicinal chemistry, 2009-12, Vol.52 (24), p.7974-7992

2009

Volltextzugriff (PDF)

Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist

Bioorganic & medicinal chemistry, 2012-02, Vol.20 (3), p.1201-1212

2012

Volltextzugriff (PDF)

Identification of 4-[1-[3-chloro-4-[N'-(5-fluoro-2-methylphenyl)ureido]pheny lacetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist

Bioorganic & medicinal chemistry, 2008-12, Vol.16 (23), p.9991-10000

2008

Volltextzugriff (PDF)

Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists

Bioorganic & medicinal chemistry, 2007-02, Vol.15 (4), p.1679-1693

2007

Volltextzugriff (PDF)

Re-examination of JFA digital health research (2019-2021): After cools down of SaMD Rhapsody

The Journal of Information Science and Technology Association, 2024, pp.2024-024

2024

Volltextzugriff (PDF)

Re-examination of JFA digital health research (2019-2021): After cools down of SaMD Rhapsody

The Journal of Information Science and Technology Association, 2024, Vol.74(Special_Issue), pp.2024-024-2024-024

2024

Volltextzugriff (PDF)

4-(Pyrrolidinyl)methoxybenzoic Acid Derivatives as a Potent, Orally Active VLA-4 Antagonist

Chemical and Pharmaceutical Bulletin, 2006, Vol.54(11), pp.1515-1529

2006

Volltextzugriff (PDF)

Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity

ACS medicinal chemistry letters, 2019-05, Vol.10 (5), p.737-742

2019

Volltextzugriff (PDF)

Synthesis and Structure-Activity Relationships of Novel 2', 2'-Difluoro Analogues of Docetaxel

Chemical and Pharmaceutical Bulletin, 1997/11/15, Vol.45(11), pp.1793-1804

1997

Volltextzugriff (PDF)

A novel inhibitor stabilizes the inactive conformation of MAPK‐interacting kinase 1

Acta crystallographica. Section F, Structural biology communications, 2018-03, Vol.74 (3), p.156-160

2018

Volltextzugriff (PDF)

JFAデジタルヘルス研究会調査の振り返り: SaMD狂想曲の冷めた後で

情報の科学と技術, 2024, Vol.74(Special_Issue), pp.2024-024-2024-024

2024

Volltextzugriff (PDF)

Discovery of imidazo[1,2- b]pyridazine derivatives as IKKβ inhibitors. Part 1: Hit-to-lead study and structure–activity relationship

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (17), p.5113-5118

2010

Volltextzugriff (PDF)

Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6455-6469

2016

Volltextzugriff (PDF)

A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid

Bioorganic & medicinal chemistry, 2013-01, Vol.21 (1), p.42-61

2013

Volltextzugriff (PDF)

A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid

Bioorganic & medicinal chemistry, 2009-02, Vol.17 (3), p.1232-1243

2009

Volltextzugriff (PDF)

Synthesis and Antitumor Activity of Non-Prodrug Water-soluble Taxoid: 10-C-Aminoalkylated Docetaxel Analogs

Heterocycles, 2000-12, Vol.53 (12), p.2719

2000

Volltextzugriff (PDF)

A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazo l yl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmeth o x y]cyclohexanecarboxylic acid

Bioorganic & medicinal chemistry, 2013-01, Vol.21 (1), p.42-61

2013

Volltextzugriff (PDF)

Identification of 4-[1-[3-chloro -4-[N'-(5-fluoro-2-methylphenyl)ureido]phenyl-acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist

Bioorganic & medicinal chemistry, 2008-12, Vol.16 (23), p.9991-10000

2008

Volltextzugriff (PDF)

Identification of 4-[1-[3-chloro-4-[ N’-(5-fluoro-2-methylphenyl)ureido]phenylacetyl]-(4 S)-fluoro-(2 S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist

Bioorganic & medicinal chemistry, 2008-12, Vol.16 (23), p.9991-10000

2008

Volltextzugriff (PDF)

Discovery of ans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4s)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist

Journal of medicinal chemistry, 2009, Vol.52 (24), p.7974-7992

2009

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(129)
Berichte
(1)

Sprache

Englisch
(108)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Discovery of 3‑(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl‑3H‑imidazo[4,5‑b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor

Discovery of imidazo[1,2- b]pyridazines as IKKβ inhibitors. Part 3: Exploration of effective compounds in arthritis models

Discovery of imidazo[1,2- b]pyridazines as IKKβ inhibitors. Part 2: Improvement of potency in vitro and in vivo

Enantioselective Total Synthesis of Guanacastepene N Using an Uncommon 7-Endo Heck Cyclization as a Pivotal Step

A Novel Inhibitor of I-KappaB Kinase Beta Ameliorates Experimental Arthritis through Downregulation of Proinflammatory Cytokines in Arthritic Joints

Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist

Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist

Identification of 4-[1-[3-chloro-4-[N'-(5-fluoro-2-methylphenyl)ureido]pheny lacetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist

Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists

Re-examination of JFA digital health research (2019-2021): After cools down of SaMD Rhapsody

Re-examination of JFA digital health research (2019-2021): After cools down of SaMD Rhapsody

4-(Pyrrolidinyl)methoxybenzoic Acid Derivatives as a Potent, Orally Active VLA-4 Antagonist

Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity

Synthesis and Structure-Activity Relationships of Novel 2', 2'-Difluoro Analogues of Docetaxel

A novel inhibitor stabilizes the inactive conformation of MAPK‐interacting kinase 1

JFAデジタルヘルス研究会調査の振り返り: SaMD狂想曲の冷めた後で

Discovery of imidazo[1,2- b]pyridazine derivatives as IKKβ inhibitors. Part 1: Hit-to-lead study and structure–activity relationship

Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor

A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid

A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid

Synthesis and Antitumor Activity of Non-Prodrug Water-soluble Taxoid: 10-C-Aminoalkylated Docetaxel Analogs

A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazo l yl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmeth o x y]cyclohexanecarboxylic acid

Identification of 4-[1-[3-chloro -4-[N'-(5-fluoro-2-methylphenyl)ureido]phenyl-acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist

Identification of 4-[1-[3-chloro-4-[ N’-(5-fluoro-2-methylphenyl)ureido]phenylacetyl]-(4 S)-fluoro-(2 S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist

Discovery of ans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4s)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist

Suchergebnisse filtern